본문 바로가기
KERD
논문KCI 등재

Protection Provided by a Gabexate Mesylate Thermo-Sensitive In Situ Gel for Rats with Grade III Pancreatic Trauma

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background/Aims: This study investigated the protection provided by gabexate mesylate thermo-sensitive in-situ gel (GMTI) against grade III pancreatic trauma in rats. Methods: A grade III pancreatic trauma model with main pancreatic duct dividing was established, and the pancreas anatomical diagram, ascites, and serum biochemical indices, including amylase, lipase, C-reactive protein (CRP), interleukin 6 (IL- 6), and tumor necrosis factor-α (TNF-α), were examined. The pancreas was sliced and stained with hematoxylin eosin and subjected to terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Results: Ascites, serum amylase, lipase, CRP, IL-6, and TNF-α levels were significantly increased in the pancreas trauma (PT) groups with prolonged trauma time and were significantly decreased after GMTI treatment. The morphological structure of the pancreas was loose, the acinus was significantly damaged, the nuclei were irregular and hyperchromatic, and there was inflammatory cell invasion in the PT group compared to the control. After GMTI treatment, the morphological structure of the pancreas was restored, and the damaged acinus and inflammatory cell invasion were decreased compared to the PT group. Moreover, the cell apoptosis index was significantly increased in the PT group and restored to the same levels as the control group after GMTI treatment. Conclusions: GMTI, a novel formulation and drug delivery method, exhibited specific effective protection against PT with acute pancreatitis therapy and has potential value as a minimally invasive adjuvant therapy for PT with acute pancreatitis.

Abstract

Background/Aims: This study investigated the protection provided by gabexate mesylate thermo-sensitive in-situ gel (GMTI) against grade III pancreatic trauma in rats. Methods: A grade III pancreatic trauma model with main pancreatic duct dividing was established, and the pancreas anatomical diagram, ascites, and serum biochemical indices, including amylase, lipase, C-reactive protein (CRP), interleukin 6 (IL- 6), and tumor necrosis factor-α (TNF-α), were examined. The pancreas was sliced and stained with hematoxylin eosin and subjected to terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Results: Ascites, serum amylase, lipase, CRP, IL-6, and TNF-α levels were significantly increased in the pancreas trauma (PT) groups with prolonged trauma time and were significantly decreased after GMTI treatment. The morphological structure of the pancreas was loose, the acinus was significantly damaged, the nuclei were irregular and hyperchromatic, and there was inflammatory cell invasion in the PT group compared to the control. After GMTI treatment, the morphological structure of the pancreas was restored, and the damaged acinus and inflammatory cell invasion were decreased compared to the PT group. Moreover, the cell apoptosis index was significantly increased in the PT group and restored to the same levels as the control group after GMTI treatment. Conclusions: GMTI, a novel formulation and drug delivery method, exhibited specific effective protection against PT with acute pancreatitis therapy and has potential value as a minimally invasive adjuvant therapy for PT with acute pancreatitis.

참고문헌 (35)

  1. Dawson AR, "Rupture of the head of the pancreas by blunt trauma: a case report", S Afr Med J, 67, pp.560~562 (1985)
  2. Pustovoĭ IP, "Isolated closed trauma of the pancreas", Klin Khir, (11), pp.58~ (1978)
  3. Rui-Wu D, "Cell cycle characteristics of the pancreas in an animal model of isolated pancreatic trauma", J Trauma Acute Care Surg, 76, pp.784~790 (2014)
  4. Pavel MC, "Abdominal trauma with complete rupture of the pancreas", Cir Esp, 91, pp.457~ (2013)
  5. Gupta A, "Blunt trauma of the pancreas and biliary tract: a multimodality imaging approach to diagnosis", Radiographics, 24, pp.1381~1395 (2004)
  6. Silveira HJ, "Trauma of pancreas: predictor’s factors of morbidity and mortality related to trauma index", Arq Gastroenterol, 46, pp.270~278 (2009)
  7. Boffard KD, "Pancreatic trauma: injuries to the pancreas and pancreatic duct", Eur J Surg, 166, pp.4~12 (2000)
  8. Mahajan A, "Utility of serum pancreatic enzyme levels in diagnosing blunt trauma to the pancreas: a prospective study with systematic review", Injury, 45, pp.1384~1393 (2014)
  9. Schein M, "Current management of trauma to the pancreas", Br J Surg, 79, pp.717~718 (1992)
  10. Laaninen M, "Difference in early activation of NF-kappaB and MCP-1 in acinar-cellrich versus fibrotic human pancreas exposed to surgical trauma and hypoxia", Gastroenterol Res Pract, 2014, pp.460363~ (2014)
  11. Shneĭder VE, "Experimental substantiation of the treatment of pancreas trauma using ultralow temperatures", Eksp Klin Gastroenterol, (7), pp.45~49 (2008)
  12. Gigante A, "Gabexate mesylate as treatment in the course of ANCA-negative microscopic polyangiitis", Ren Fail, 35, pp.721~724 (2013)
  13. Matsukawa Y, "Anaphylaxis induced by gabexate mesylate", BMJ, 317, pp.1563~ (1998)
  14. Menegatti E, "Gabexate mesylate inhibition of serine proteases:thermodynamic and computer-graphics analysis", J Pharm Sci, 75, pp.1171~1174 (1986)
  15. Yasunaga H, "Effect and cost of treatment for acute pancreatitis with or without gabexate mesylate: a propensity score analysis using a nationwide administrative database", Pancreas, 42, pp.260~264 (2013)
  16. Zheng MH, "Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis update", Curr Ther Res Clin Exp, 69, pp.288~304 (2008)
  17. Ke L, "Efficacy of continuous regional arterial infusion with low-molecular-weight heparin for severe acute pancreatitis in a porcine model", Shock, 41, pp.443~448 (2014)
  18. Hamada T, "Continuous regional arterial infusion for acute pancreatitis: a propensity score analysis using a nationwide administrative database", Crit Care, 17, pp.R214~ (2013)
  19. Chiang PR, "Thermosensitive hydrogel from oligopeptide-containing amphiphilic block copolymer: effect of peptide functional group on self-assembly and gelation behavior", Langmuir, 29, pp.15981~15991 (2013)
  20. Li K, "A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel", Biomaterials, 34, pp.2834~2842 (2013)
  21. Ruokolainen J, "Temperature controlled release from polystyrene-block-poly(N-isopropylacrylamide-block-polystyrene block copolymer hydrogel", J Control Release, 148, pp.e53~e54 (2010)
  22. Moore EE, "Organ injury scaling, II: pancreas, duodenum, small bowel, colon, and rectum", J Trauma, 30, pp.1427~1429 (1990)
  23. Vezakis A, "Complete traumatic main pancreatic duct disruption treated endoscopically: a case report", J Med Case Rep, 8, pp.173~ (2014)
  24. Kuroki T, "Surgical strategy for main pancreatic duct-type intraductal papillary mucinous neoplasm of the pancreas", Hepatogastroenterology, 59, pp.2631~2634 (2012)
  25. Koshita S, "Localized autoimmune pancreatitis, 9 mm in size, without strictures of the main pancreatic duct", Gastrointest Endosc, 75, pp.920~922 (2012)
  26. Subramanian A, "The management of pancreatic trauma in the modern era", Surg Clin North Am, 87, pp.1515~1532 (2007)
  27. Hamidian Jahromi A, "Surgical versus nonsurgical management of traumatic major pancreatic duct transection:institutional experience and review of the literature", Pancreas, 42, pp.76~87 (2013)
  28. Bourges JL, "Drug delivery systems for intraocular applications", J Fr Ophtalmol, 30, pp.1070~1088 (2007)
  29. Rincón Alarcón A, "Intraocular drug delivery systems", Arch Soc Esp Oftalmol, 81, pp.57~59 (2006)
  30. Xie B, "An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease", Int J Pharm, 490, pp.375~383 (2015)
  31. Baral A, "Assembly of an injectable noncytotoxic peptide-based hydrogelator for sustained release of drugs", Langmuir, 30, pp.929~936 (2014)
  32. Bujňáková Z, "Stability studies of As4S4 nanosuspension prepared by wet milling in Poloxamer 407", Int J Pharm, 478, pp.187~192 (2015)
  33. Jansen MM, "Controlled release of morphine from a poloxamer 407 gel", Int J Pharm, 452, pp.266~269 (2013)
  34. 이재협, "The Effect of Poloxamer 407-Based Hydrogel on the Osteoinductivity of Demineralized Bone Matrix", Clinics in Orthopedic Surgery, 6(4), pp.455~461 (2014), 대한정형외과학회
  35. Cespi M, "Evaluation of thermosensitive poloxamer 407 gel systems for the sustained release of estradiol in a fish model", Eur J Pharm Biopharm, 88, pp.954~961 (2014)

관련 논문AI추천

이 간행물의 다른 논문 (26건)